-
Insights Into Astrazeneca Q1: Wall Street Projections for Key Metrics
22 Apr 2024 21:47 GMT
In its upcoming report, Astrazeneca AZN is predicted by … the average estimates of some Astrazeneca metrics that Wall Street … that 'Product Sales- CVRM- Onglyza' will reach $49.01 … .
Over the past month, Astrazeneca shares have recorded returns of …
-
2023 First Generic Drug Approvals
08 Mar 2024 22:36 GMT
… Bulk Package
B. Braun Medical, Inc.
Calcium Gluconate in … 5 mg
Sun Pharmaceutical Industries Limited
Onglyza (Saxagliptin) Tablets
7 … , once-daily, maintenance treatment of bronchospasm associated with … are refractory to other drugs
18
213267
Thalidomide …
-
AstraZeneca gets CDSCO Panel Nod To update Prescribing Information of Antidiabetic FDC
07 Mar 2024 18:16 GMT
… .”
This came after the drug major AstraZeneca presented the proposal for an … .11.2022.
Saxagliptin (Onglyza) is an oral antihyperglycemic drug in the dipeptidyl … is in a class of medications called sodium-glucose co-transporter …
-
Royalty Pharma Reports First Quarter 2024 Results
09 May 2024 11:00 GMT
… acquisition of Karuna. Bristol Myers acquired Karuna for … New Drug Application for KarXT for the treatment of … -cap biotechnology companies to leading global pharmaceutical companies. … Emgality, Entyvio, Farxiga/Onglyza, IDHIFA, Letairis, Lexiscan, Mircera …
-
Appeals court: Diabetes drug causation claims don’t stand up
15 Feb 2024 00:09 GMT
… that Onglyza (saxagliptin) and Kombiglyze (saxagliptin/metformin hydrochloride), developed by Astrazeneca … plc and Bristol Myers Squibb Co., caused …
-
Appeals court sides with AstraZeneca, BMS, McKesson in saxagliptin heart failure case
14 Feb 2024 20:04 GMT
… a decision in favor of AstraZeneca, Bristol Myers Squibb and McKesson in … the discontinued type 2 diabetes treatments Onglyza and Kombiglyze. It’s a … exercise. But in 2016, an FDA safety review found that saxagliptin …
-
Case Dismissed: Appeals Court Slams Expert Witness in Diabetes Drug Lawsuits
15 Feb 2024 07:56 GMT
… dozens of others against Bristol-Myers Squibb Co., AstraZeneca Pharmaceuticals and two more … of Medicine. Goyal said that saxagliptin, sold under the brand name Onglyza … the FDA, which triggered many class-action lawsuits against the drug manufacturers …
-
AstraZeneca PLC (LON:AZN) Announces Dividend of GBX 156
09 Feb 2024 13:37 GMT
… on AZN
About AstraZeneca
(Get Free Report)
AstraZeneca PLC, a biopharmaceutical … development, manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …
-
Janney Montgomery Scott LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
09 Feb 2024 13:31 GMT
… Our Latest Stock Analysis on AstraZeneca
AstraZeneca Stock Performance
Shares of … , manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …
-
AstraZeneca PLC (NASDAQ:AZN) Receives $80.00 Consensus Target Price from Brokerages
09 Feb 2024 08:40 GMT
… fiscal year.
About AstraZeneca
(Get Free Report
AstraZeneca PLC, a biopharmaceutical … , manufacture, andcommercialization of prescription medicines. The company's marketed … Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and …